N 6 -methyladenosine (m 6 A) is a conserved internal modification prevalent in eukaryotic nuclear RNA and determines stem cell fates by influencing mRNA metabolism, especially mRNA stability. 1 The m 6 A modification is imprinted by a 'writer' multicomponent N 6 -adenosine methyltransferase (MT) complex composed of METTL3 and METTL14. 2 These two proteins form a stable heterodimer to catalyse M 6 mRNA methylation. In their recent paper in Nature, Li et al. 3 demonstrate that ablating the MT complex prevents m 6 A modification and leads to a dramatic alteration of lymphocyte homeostasis where T cells are kept in a naive state.
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Stimulating CD4 T cells with antigen in the presence of certain cytokines polarizes their function: IL-12 generates T helper 1 (Th1 cells) synthesizing IFNγ, whereas IL-4 stimulates Th2 cells producing IL-4. 3 With the knowledge that m 6 A modification of mRNA determines stem cell fate, 1 Li et al. 3 tested whether m 6 A might also control T helper cell differentiation. To address this question, the authors prepared CD4-CRE conditional Mettl3 flox/flox mice; T cells from these mice showed an absence of METTL3 and also METTL14 proteins and displayed a marked (72%) decrease in overall RNA m 6 A methylation levels relative to wild-type (WT) T cells. This deficit had no discernible effect on thymocyte differentiation or cellularity. For spleen and lymph nodes (LN), however, the proportion of mature CD4 T cells with a naive CD44 lo CD62L hi phenotype was substantially higher, especially in LN (~80%), than in WT CD4 cells (~55%).
When analysed for their function in vitro, the mettl3 − / − -naive CD4 T cells showed no abnormality in their proliferative response to graded doses of beads coated with CD3 and CD28 antibodies, implying normal sensitivity to TCR signalling. However, when tested for T helper polarization, the KO CD4 cells displayed a significant reduction in production of Th1 and also Th17 cells, paralleled by an increase in Th2 generation, but no change in numbers of CD4 + Foxp3 + T regulatory cells. Next, the authors switched to an in vivo model to examine cytokine-dependent homeostatic proliferation of T cells in lymphopenic hosts. Confirming previous findings of others, 4, 5 transfer of naive WT CD4 cells into Rag2 −/− hosts led to marked proliferation and expansion of the donor T cells followed by their differentiation into effector cells and induction of severe colitis. Remarkably, these changes were entirely absent with transfer of Mettl3 −/− CD4 cells. Here, the donor T cells maintained their naive phenotype and failed to expand: by 4 weeks after injection, total yields of the donor KO cells in host lymphoid tissues were 400-fold less than in recipients of WT cells. The poor recovery of the KO cells did not seem to reflect rejection because re-inserting Mettl3 into the KO cells restored their capacity to differentiate into effector T cells.
Since typical homeostatic proliferation of T cells in lymphopenic mice is driven by the raised levels of IL-7 in these hosts, 4 the authors speculated that the lack of KO T cell proliferation seen in the lymphopenic hosts reflected defective signalling through the IL-7R. In support of this notion, phosphorylation of JAK1 and STAT5 after culture with IL-7 was much lower with the KO T cells than with WT cells. This finding raised the question of how the KO T cells were able to survive long-term in vivo, given the known role of IL-7 in naive T-cell survival. 4 Interestingly, the authors found that the KO T cells displayed a significant increase in basal ERK and AKT signalling, which they suggested was sufficient to bypass the requirement for IL-7 signalling to maintain viability in resting KO T cells, in their words: 'thus uncoupling T-cell proliferation from cell survival'.
In assessing how RNA m 6 A methylation affects IL-7 signalling, Li et al. 3 defined Socs1, Socs3 and Cish as m 6 A targets and demonstrated that levels of these three genes and their proteins were all increased in Mettl3 −/− T cells and correlated with slower mRNA decay. These findings fitted well with their data because SOCS1, SOCS3 and CISH are known to be negative regulators of IL-7 signalling, STAT5 phosphorylation and proliferation, and can also augment ERK activity by binding to RasGAP. Notably, siRNAmediated Socs1 knockdown of Mettl3 − / − T cells restored their capacity to proliferate in Rag2 −/− hosts. Further studies showed that stimulation of T cells with IL-7 led to rapid degradation of Socs1, Socs3 and Cish mRNA in WT T cells but not in mettl3 −/− T cells. On the basis of these and the above findings, the authors proposed a model where m 6 A modification is a conserved mechanism for regulating the degradation of a group of immediate-early response genes, notably Socs genes, in response to environmental stimuli (IL-7), thereby promoting sensitivity to these stimuli. Without m 6 A, Socs mRNA persists, thereby leading to high levels of SOCS proteins and reduced sensitivity to IL-7.
Although this elegant model (Figure 1 ) agrees closely with the data presented, the model hinges heavily on the assumption that the proliferation seen with T-cell transfer into Rag2 −/− hosts is entirely IL-7 dependent. Here it should be noted that IL-7-dependent T-cell proliferation is generally measured in T-cellsufficient hosts made acutely lymphopenic by exposure to irradiation. 4 With constitutively chronic lymphopenic Rag2 −/− mice, by contrast, proliferation of naive T cells transferred into these hosts has two distinct components: a large proportion of T cells that proliferates slowly to IL-7, and a smaller subset that proliferates rapidly and progressively in response to gut antigens. 4 These two populations of slow-and fast-proliferating T cells are clearly seen in Figure 2b of the paper of Li et al. 3 at 2 weeks after transfer of WT T cells. However, by 4 weeks only the fastproliferating cells are apparent, indicating massive expansion of these T cells. Since fast T-cell proliferation in Rag2 −/− hosts is minimal in germ-free mice, the response is largely TCR driven and IL-7 independent. 4 How then can the data of Li et al. 3 be explained? Since SOCS proteins are known to regulate responsiveness not only to IL-7 but also to IL-2 and other γc cytokines, 6 the lack of expansion of Mettl3 −/− T cells in Rag2 −/− hosts might be attributed to defective signalling via IL-2 rather than IL-7. On this point, it is known that prolonged expansion of CD4 T-cell responses to antigen in vivo is heavily IL-2 dependent and that lack of IL-2 causes rapid elimination of the responding T cells. 7 This idea could be easily tested with CD8 T cells, which are much more sensitive to IL-2 and other cytokines than naive CD4 T cells.
Nevertheless, the problem remains that Li et al. 3 saw almost no fast-proliferating T cells in Rag −/− hosts, implying a lack of TCRdependent responses. This observation seems at odds with their finding of normal T proliferation elicited by CD3/CD28 ligation in vitro. Yet it is notable that, in addition to inhibiting cytokine signalling, SOCS1, 8 SOCS3 9 and CISH 10 proteins all also impair TCR signalling, which is in line with the marked decrease of Th1 and Th17 cells seen with the KO T cells. Hence, in future studies, it would be informative to further scrutinize Mettl3 −/− T cells for possible TCR signalling defects, especially with the aid of TCR transgenic T cells and specific peptides, both in vitro and in vivo. For IL-7 signalling, comparison of T-cell proliferation in acutely irradiated versus Rag2 −/− hosts would be equally informative.
Despite these questions, the paper of Li et al. 3 presents decisive evidence that for certain genes the pattern of mRNA methylation can have a dramatic influence on T cell homeostasis. This is the real novelty of the paper. Figure 1 The paper of Li et al. 3 demonstrates that the extent of m 6 A methylation of mRNA can markedly affect T-cell function. In WT cells, the action of the METTL3/METTL14 methyltransferase (MT) complex leads to prominent m 6 A modification of Socs1, Socs3, Cish, which promotes rapid mRNA degradation after cell contact with IL-7: inhibition by SOCS proteins is blocked, thereby promoting IL-7 signalling. With Mettl3 deletion, m 6 A mRNA methylation is reduced, leading to impaired degradation of Socs mRNA, raised levels of SOCS proteins and inhibition of sensitivity to IL-7, and possibly other γc cytokines.
